Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Andresen, , Helene,
DOB: 17-OCT-1939 (Age: 86)
Gender: female
Address:
Kristiansenberget 2
0172 Sørensen (Norway)
ID: 3450-170343-2 (ECI)
Report
Date: 09-OCT-2016
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Oslo universitetssykehus (Ullevål)
0155 Oslo (Norway)
Specimen
Collected: 08-OCT-2016

Chemistry

Test 09-OCT-2016 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.9 4.5 - 6.4 %
Glucose [Mass/volume] in Blood 76.0 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 18.9 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 0.6 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.4 8.6 - 10.4 mg/dL
Sodium [Moles/volume] in Blood 136.8 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 3.8 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 103.4 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 23.7 22 - 32 mmol/L

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All measured laboratory values are within normal limits for this 85-year-old female patient. No evidence of acute metabolic, renal, or electrolyte disturbances. Glycemic control appears adequate. No laboratory abnormalities detected at this time. Recommend continued routine monitoring as clinically indicated.